Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Compound Kushen Gel for bacterial vaginosis
CTR20240680Phase 3Active
- Sponsor
- Guiyang Xintian Pharmaceutical Co., Ltd.
- Start
- Apr 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Compound Kushen Gel in bacterial vaginosis (BV), sponsored by Guiyang Xintian Pharmaceutical Co., Ltd.. Started Apr 2024; status: active.
02
Drugs
Compound Kushen Gel
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on CTR20240680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240680.